Loading...
Alemtuzumab in Multiple Sclerosis: Lessons from Social Media in Enhancing Patient Care
BACKGROUND: Alemtuzumab is a monoclonal antibody that has been approved for the treatment of relapsing-remitting multiple sclerosis (MS). Alemtuzumab is associated with infusion reactions and potential autoimmune complications. Patient education and understanding are crucial to favorable outcomes. O...
Na minha lista:
| Udgivet i: | Int J MS Care |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Consortium of Multiple Sclerosis Centers
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5734716/ https://ncbi.nlm.nih.gov/pubmed/29270090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073.2017-010 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|